AMARANTUS AND BSI ANNOUNCE CONTINUED SUPPORT OF ONE MIND
At 3rd #C4CT Concussion Awareness Summit at United Nations
Posted on July 16, 2014
MINNEAPOLIS, MN, SAN FRANCISCO, CA AND GENEVA, SWITZERLAND – July 16, 2014 – Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to cell cycle dysregulation, endoplasmic reticulum stress, neurodegeneration and apoptosis, are pleased to announce their continued support of One Mind at the 3rd Alzheimer’s focused #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit, powered by MDM Worldwide on Thursday, July 31, 2014 at the United Nations in New York City, NY.
ONE MIND is an independent, 501 (c)(3) non-profit organization devoted to bringing together the public and private sectors to collaborate on large-scale, shared data research for all diseases of the brain; research that will accelerate the development and implementation of improved diagnostics, treatments, and cures for patients.
"Forging partnerships and collaborations are critical to making much needed progress in finding better diagnostics and treatments for concussions, CTE’s and TBI’s in sports and beyond." - Pete Chiarelli, CEO of One Mind, U.S. Army General (Retired)
The #C4CT Concussion Awareness Summit is being convened on July 31, 2014 to explore the potential link between TBI and Alzheimer’s disease. A diverse working group of clinicians, medical researchers, policy makers, international diplomats, athletes, celebrities, and philanthropic organizations will be assembled to raise awareness, advance clinical research, and develop public policy in order to address this major unmet medical need and public health issue.
The Summit will feature multiple panelists and presenters including an opening keynote by The Honorable Chaka Fattah (D-PA), Member of Congress; Chris Nowinski, Co- Founder & Executive Director of Sports Legacy Institute; Co-Director for the Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine; Former WWE Wrestler, Robert Stern, Ph.D., Boston University School of Medicine; and Robert Cantu, M.A., M.D., F.A.C.S., F.A.A.N.S., F.I.C.S., F.A.C.S.M., Boston University School of Medicine and Sport Legacy Institute (SLI). There will also be a special panel of current and former professional athletes who will share personal stories about their experiences with concussions.
To register or for additional information, please visit www.c4ctsummit.com. For further event questions, please contact Lindsay Lommel at email@example.com. For sponsorship information please visit: http://www.c4ctsummit.com/sponsorship-opportunities/.
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. AMBS has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD. AMBS has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test(R)") for Alzheimer's disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. AMBS also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard"). Amarantus operations are located at Janssen Labs @QB3 in San Francisco, CA. For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Brewer Sports International (BSI) is a multi-faceted sports advisory firm within The Brewer Group Companies with a focus on the business of sports, wellness and media for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. Jack Brewer, five-year National Football League (NFL) veteran and former three-team captain, launched BSI in Minneapolis and expanded to New York, Dallas, Miami, Beijing and Malawi. BSI offers a unique financial services platform to professional athletes and sports agencies, as well as high-net-worth individuals and businesses related to professional sports. BSI takes pride in enabling its clients to capitalize on the endless opportunities presented through sport. For more information, please visit www.brewersports.com or follow them on Facebook, Twitter and LinkedIn.
About One Mind
One Mind is an independent, 501(c)(3) non-profit organization dedicated to benefiting all affected by brain illness and injury through fostering fundamental changes that will radically accelerate the development and implementation of improved diagnostics, treatments, and cures; while eliminating the stigma. One Mind believes in open science principles and creates global public-private partnerships between governmental, corporate, scientific, and philanthropic communities. Visit us at www.onemind.org or follow us via Twitter or Facebook.
Brewer Sports International:
Kristi Hofacker, Interactive Marketing and Media Manager
Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Investor Relations
408.737.2734 x 101
Office: +1 206.946.1768